Engimata Inc

Larix Bioscience LLC is a biotechnology company based in Sunnyvale, CA that specializes in the development of therapeutic antibodies for various medical conditions, including anorexia nervosa, preeclampsia, hyperemesis gravidarum, Alzheimer's disease, COVID-19, myocardial ischemia-reperfusion injury, cancer-associated cachexia, hypercholesterolemia, idiopathic pulmonary fibrosis, and Netherton syndrome. With a focus on innovative therapies, Larix Bioscience aims to address unmet clinical needs and improve the quality of life for patients suffering from these debilitating conditions. Through their research and development efforts, Larix Bioscience is dedicated to advancing novel treatments and therapies that have the potential to make a significant impact in the field of healthcare. With a team of experts and a commitment to scientific excellence, the company strives to bring innovative solutions to the market that can improve patient outcomes and contribute to the advancement of medical science.Generated from the website

Exelixis is an integrated drug discovery and development company. The company utilizes cutting-edge genomic, molecular biology and combinatorial chemistry technologies to develop innovative therapies for significant human diseases. Its primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease. Exelixis has built a research and discovery platform. The Exelixis clinical development pipeline includes compounds in cancer and renal disease. The company s pre-clinical pipeline is comprised of six programs. The pre-clinical oncology programs consist of development candidates that focus on inhibiting kinases. In its pre-clinical metabolic disease programs, Exelixis has developed small molecules that modulate nuclear hormone receptors that implicate various metabolic and cardiovascular disorders. Corporate headquarters are in San Francisco. The research facility is in Portland, Ore.

PH Pharma Inc is a global pharmaceutical company with research centers in both Palo Alto, CA and Seongnam-si, Gyeonggi-do. With a focus on developing innovative drug programs, they have established themselves as a leader in the industry. Driven by a strong strategy and supported by strategic partnerships, PH Pharma Inc has a robust pipeline of programs, including ADC Sovesudil, aimed at addressing various medical needs. Their commitment to excellence and dedication to improving healthcare make them a prominent player in the pharmaceutical field.Generated from the website